HBV-specific monoclonal antibody (SAMBA Study)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HBV-specific monoclonal antibody (SAMBA Study), covering 2024-10-31 to 2024-10-31. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody (The SAMBA Study) [Phase 1]